Skip to main content

Laura

Analyst

Alliance Global Partners

Equibles does not estimate personal net worth.

About Laura

Laura is recorded as Analyst at Alliance Global Partners. Laura has spoken on 3 earnings calls across 3 companies, most recently for BioCardia, Inc. on November 12, 2026. Those appearances were for BioCardia, Inc. (BCDA), Acurx Pharmaceuticals, Inc. (ACXP) and Helus Pharma Inc. (HELP). The companies whose calls Laura spoke on are classified in the Healthcare sector.

Laura on recent calls

“So on Cardi Amp, maybe you just talk a bit more about what a launch in Japan could look like and some of the logistics behind getting the post-marketing study started.”
Analyst — Alliance Global Partners, BioCardia, Inc. Q3 FY2026 Earnings Call ·
“So just a bit more on the Pathfinder 2 trial. I know it's a bit early still, but could you provide a bit more insight on what the study design might look like and how long you think this trial might run and any potential costs involved?”
Analyst — Alliance Global Partners, Third Quarter Financial Results Conference Call ·
“So for the ongoing approach trial, you mentioned how you're planning to have a total of 45 clinical trial sites within the U.S. So you may provide a bit more detail on the criteria behind choosing these sites and the activation process involved, and also as well as when you might think you have all 45 of these sites…”
Analyst — Alliance Global Partners, Q2 Financial Results Conference Call and Webcast ·

Affiliation history

  • Alliance Global Partners

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity